These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 101124)

  • 1. [About proteinic impurities checking in a meningococcal vaccine. Mannitol interference in the Lowry protein determination (author's transl)].
    Bienvenu P; Hajjar R; Fontanges R
    Ann Pharm Fr; 1978; 36(5-6):263-8. PubMed ID: 101124
    [No Abstract]   [Full Text] [Related]  

  • 2. [Observations on the reactions and preventive efficacy of lyophilized group A meningococcal polysaccharide vaccine (author's transl)].
    Song BH; Liu DG
    Zhonghua Yu Fang Yi Xue Za Zhi; 1982 Jan; 16(1):39-41. PubMed ID: 6807642
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serogroup A N. meningitidis polysaccharide vaccine and serogroup A N. meningitidis carrier state (author's transl)].
    Bencić Z; Madarić D; Manhalter T; John V; Amsel V; Weisglass H
    Lijec Vjesn; 1978 Nov; 100(11):706-7. PubMed ID: 107385
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of a bivalent meningococcal vaccine (A + C). Part II. Stability.
    Arickx M; Crooy P; De Neys R; Gilles R; Liveyns R
    Ann Soc Belg Med Trop; 1979 Sep; 59(3):267-77. PubMed ID: 117761
    [No Abstract]   [Full Text] [Related]  

  • 5. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 6. A sensitive method for the determination of the molecular size of meningococcal polysaccharide vaccine.
    Helting TB; Kumpe M
    J Biol Stand; 1978; 6(2):111-5. PubMed ID: 418071
    [No Abstract]   [Full Text] [Related]  

  • 7. [New antigenic determination of Neisseria meningitidis. I. Results of serotyping of the strains N. meningitidis isolated in CSR in the years 1976-1978 from patients with cerebrospinal meningitis and from healthy carriers (author's transl)].
    Kuzemenská P; Svandová E
    Cesk Epidemiol Mikrobiol Imunol; 1980 Dec; 29(6):360-6. PubMed ID: 6450644
    [No Abstract]   [Full Text] [Related]  

  • 8. [Active immunization for prevention of meningococcal infections].
    Kardymowicz B; Rymkiewicz D
    Przegl Epidemiol; 1980; 34(2):193-201. PubMed ID: 6776590
    [No Abstract]   [Full Text] [Related]  

  • 9. Production and control of Neisseria meningitidis vaccines.
    Frasch CE
    Adv Biotechnol Processes; 1990; 13():123-45. PubMed ID: 2110462
    [No Abstract]   [Full Text] [Related]  

  • 10. [Application of the indirect hemagglutination test for the determination of titres of meningococcal antibodies (author's transl)].
    Weisglass H; Polovina-Mestrović B; Vlajcević E; Amsel V; Bencić Z
    Lijec Vjesn; 1979 Aug; 101(8):470-2. PubMed ID: 120476
    [No Abstract]   [Full Text] [Related]  

  • 11. [The new Norwegian meningococcal vaccine].
    Bjune G
    Tidsskr Nor Laegeforen; 1987 Nov; 107(32):2868-9. PubMed ID: 3122361
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccine against meningococcal disease.
    Narain JP; Mukherjee D
    Indian Pediatr; 1985 Jun; 22(6):405-7. PubMed ID: 3938975
    [No Abstract]   [Full Text] [Related]  

  • 13. [efficacy of the polysaccharide vaccine of Neisseria meningitidis group A].
    Yuan CD
    Zhonghua Liu Xing Bing Xue Za Zhi; 1983 Aug; 4(4):207-10. PubMed ID: 6416682
    [No Abstract]   [Full Text] [Related]  

  • 14. Local adverse effects of meningococcal vaccine.
    Scheifele DW; Bjornson G; Boraston S
    CMAJ; 1994 Jan; 150(1):14-5. PubMed ID: 8275404
    [No Abstract]   [Full Text] [Related]  

  • 15. Change in recommendation for meningococcal vaccine for travelers.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Feb; 48(5):104. PubMed ID: 10084899
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunity against Neisseria meningitidis in different population groups].
    Pauste Ruiz H; García Imia L; Campa Huergo C; Gutiérrez Hernández M; Valcárcel Novo M
    Rev Cubana Med Trop; 1989; 41(1):135-47. PubMed ID: 2505344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal vaccine.
    Med Lett Drugs Ther; 1974 Aug; 16(18):74-5. PubMed ID: 4212159
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vaccines against Neisseria meningitidis].
    Ferrón L; Criado MT; Ferreirós CM
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002
    [No Abstract]   [Full Text] [Related]  

  • 19. Meningococcal vaccines.
    Poolman JT
    J Med Microbiol; 1988 Jul; 26(3):170-2. PubMed ID: 3134548
    [No Abstract]   [Full Text] [Related]  

  • 20. Meningococcal protein antigens and vaccines.
    Feavers IM; Pizza M
    Vaccine; 2009 Jun; 27 Suppl 2():B42-50. PubMed ID: 19481315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.